Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Hospital Medicine

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jhm.994PMID 22076962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

  2012cited by this paper
• Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.

  2011cited by this paper
• Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

  2011cited by this paper
• A potential role for daptomycin in enterococcal infections: what is the evidence?

  2010cited by this paper
• Management of multidrug-resistant enterococcal infections.

  2010cited by this paper
• Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents

  2010influential reference
• Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.

  2010influential reference
• Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

  2009cited by this paper
• Daptomycin Therapy for Vancomycin‐Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients

  2009cited by this paper
• New antimicrobial agents for the treatment of Gram-positive bacterial infections.

  2008cited by this paper
• Emergence and management of drug-resistant enterococcal infections

  2008cited by this paper
• Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

  2007influential reference
• Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

  2006cited by this paper
• Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia

  2006cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Quinupristin-dalfopristin and linezolid: evidence and opinion.

  2003cited by this paper
• Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs.

  2003cited by this paper
• Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia.

  2003cited by this paper
• Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.

  2002cited by this paper
• Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.

  2001cited by this paper
• Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study

  2001cited by this paper
• Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition.

  2001cited by this paper
• A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

  2000cited by this paper
• Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.

  2000cited by this paper
• Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia.

  1997cited by this paper

• Efficacy of linezolid in treating upper-extremity arteriovenous graft infection in maintenance hemodialysis patients

  2025cites this paper
• Antimicrobial resistance pattern of enterococcus species among clinical isolates in Iran: A systematic review and meta-analysis.

  2025cites this paper
• Relationship Between COVID-19 and Linezolid-Resistant Enterococci: A Retrospective Single-Center Study.

  2024cites this paper
• Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye

  2023cites this paper
• The microbial profile of infected endoprosthetic reconstructions after wide excision for patients with musculoskeletal tumors: A call for pathogen‐based practices

  2023cites this paper
• Management of Bilateral Synchronous Knee Prosthetic Joint Infection in a Patient with Infected Heart Transplant

  2023cites this paper
• A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota

  2023cites this paper
• Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection.

  2023cites this paper
• Synthesis, molecular docking and antibacterial activity of an oxadiazole-based lipoteichoic acid inhibitor and its metabolites

  2023cites this paper
• Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data

  2023cites this paper
• An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan

  2023cites this paper
• Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms.

  2022cites this paper
• Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe

  2021cites this paper
• The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis

  2021cites this paper
• In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci

  2021cites this paper
• Prevalence of Vancomycin resistant enterococci (VRE) in Ethiopia: a systematic review and meta-analysis

  2020cites this paper
• Multidrug-Resistant Organisms: Pre-transplant Evaluation and Management

  2020cites this paper
• Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis.

  2020cites this paper
• Vancomycin‐resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Hip and Knee Section, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study.

  2019cites this paper
• Daptomycin use in adult inpatients in a Canadian tertiary care setting.

  2019cites this paper
• The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution

  2019cites this paper
• Comparison of risk factors and outcomes of daptomycin‐susceptible and ‐nonsusceptible vancomycin‐resistant Enterococcus faecium infections in liver transplant recipients

  2018cites this paper
• Impact on Public Health of the Spread of High-Level Resistance to Gentamicin and Vancomycin in Enterococci

  2018cites this paper
• Periprosthetic Joint Infections Caused by Enterococci Have Poor Outcomes.

  2017cites this paper
• Comparison of Daptomycin and Linezolid in the Treatment of Vancomycin-Resistant Enterococcus faecium in the Absence of Endocarditis

  2017cites this paper
• Tratamiento de la bacteriemia por enterococo resistente a vancomicina con daptomicina versus linezolid: revisión sistemática y metanálisis

  2017cites this paper
• Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.

  2017cites this paper
• Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia

  2017cites this paper
• Genome-Based Analysis of Enterococcus faecium Bacteremia Associated with Recurrent and Mixed-Strain Infection

  2017cites this paper
• Speciation of Enterococcal Isolates in a Tertiary Care Hospital and Molecular Characterisation of Vancomycin Resistant Enterococci (VRE)

  2016cites this paper
• Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review

  2016cites this paper
• Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.

  2016cites this paper
• Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus

  2016cites this paper
• Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.

  2016cites this paper
• A single‐center experience with infections due to daptomycin‐nonsusceptible Enterococcus faecium in liver transplant recipients

  2016cites this paper
• Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

  2015cites this paper
• Multidrug-Resistant Organisms: Considerations in Antibiotic Selection and Administration

  2015cites this paper
• INFEKCIJE U BOLESNIKA S TRANSPLANTACIJOM JETRE

  2015cites this paper
• Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), Lipopeptides (Daptomycin), and Lipoglycopeptides (Telavancin)

  2015cites this paper
• Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.

  2015cites this paper
• Enterococcal endocarditis revisited.

  2015cites this paper
• Antimicrobial (Drug) Resistance

  2015cites this paper
• Vancomycin-resistente Enterokokken: Welche Therapieoptionen gibt es?

  2015cites this paper
• Vancomycin-Resistant Enterococcal Bacteremia Pharmacotherapy

  2015cites this paper
• A case of fatal daptomycin-resistant, vancomycin-resistant enterococcal infective endocarditis in end-stage kidney disease

  2015cites this paper
• Impact of Different Antimicrobial Therapies on Clinical and Fiscal Outcomes of Patients with Bacteremia Due to Vancomycin-Resistant Enterococci

  2014cites this paper
• What’s New in the Treatment of Enterococcal Endocarditis?

  2014cites this paper
• Which antibiotic for resistant Gram-positives, and why?

  2014cites this paper
• Daptomycin is safe and effective for the treatment of gram‐positive cocci infections in solid organ transplantation

  2014cites this paper
• Antibiotic resistance in Enterococcus faecium clinical isolates

  2014cites this paper
• Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.

  2014cites this paper
• Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis

  2014influential citation
• Vancomycin-Resistant Enterococcus faecium Bacteremia in a Tertiary Care Hospital: Epidemiology, Antimicrobial Susceptibility, and Outcome

  2014cites this paper
• Enterococcal Infection—Treatment and Antibiotic Resistance

  2014cites this paper
• Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections

  2014cites this paper
• Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.

  2014cites this paper
• Vancomycin‐Resistant Enterococcus Infections in Solid Organ Transplantation

  2013cites this paper
• Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream Infections

  2013cites this paper
• Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.

  2013cites this paper
• Contemporary Drug Treatment of Infective Endocarditis

  2013cites this paper
• Vancomycin‐resistant enterococcal meningitis in an autologous stem cell transplant recipient cured with linezolid

  2013cites this paper
• Treatment of Vancomycin-Resistant Enterococcal Bacteremia in an Observational Cohort of Neutropenic Oncology Patients: Daptomycin Versus Linezolid

  2013cites this paper
• Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review

  2013influential citation
• Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia

  2013cites this paper
• Multidrug-Resistant Bacteria in Organ Transplantation: An Emerging Threat with Limited Therapeutic Options

  2013cites this paper
• Whole-Genome Analysis of a Daptomycin-Susceptible Enterococcus faecium Strain and Its Daptomycin-Resistant Variant Arising during Therapy

  2012cites this paper
• Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content

  2012cites this paper
• Low Rate of Infection Control in Enterococcal Periprosthetic Joint Infections

  2012cites this paper